Skip to content
Screener

Precigen PGEN Product revenues, net — Total revenues

Other product segments

Papzimeos
$21.59M
Exemplar
$1.33M

Similar metrics at other companies

Rhythm Pharmaceuticals, Inc. logo
RYTMProduct revenue, net — Total revenues
$60.11M+59.4%
Geron logo
GERNProduct revenue, net — Total revenues
$57.47M+17.3%
Quanterix Corporation logo
QTRXProduct revenue — Total revenues
$25.48M+22.9%
Cactus logo
WHDProduct revenue — Total revenues
$297.24M+42.2%
Kinetik Holdings logo
KNTKProduct revenue — Total revenues
$312.23M-0.1%
Geron logo
GERNGross product revenue — Total revenues
$72.44M+25.2%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.47B+358%
Enterprise value$2.56B+382%
P/S93.2×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Precigen’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001356090-26-000017
(Amounts in thousands, except share and per share data)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Revenues
Product revenues, net$21,828$203
Service revenues1,4241,138
Total revenues23,2521,341
Operating Expenses
Cost of products and services2,5591,100
Research and development5,63810,478
Selling, general and administrative21,04912,359

Item 1. Condensed Consolidated Financial Statements

FAQ

What is Precigen's product revenues, net — total revenues?
Precigen (PGEN) reported product revenues, net — total revenues of $21.83M in Q1 2026.
How has Precigen's product revenues, net — total revenues changed year-over-year?
Precigen's product revenues, net — total revenues increased by 10652.7% year-over-year, from $203K to $21.83M.
What is the long-term trend for Precigen's product revenues, net — total revenues?
Over 4 years (2021 to 2025), Precigen's product revenues, net — total revenues has grown at a -15.9% compound annual growth rate (CAGR), from $7.93M to $3.98M.
What does product revenues, net — total revenues mean?
This metric represents the net revenue generated specifically from the sale of products or commercialized synthetic biology solutions to external customers. It reflects the company's ability to successfully transition its proprietary gene program technologies into marketable goods that generate recurring sales. Tracking this figure provides insight into the commercial adoption and market demand for the company's specialized biotechnology offerings.

Ask your AI about Precigen's product revenues, net — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude